AI assistant
Orkla ASA — Share Issue/Capital Change 2014
Oct 10, 2014
3703_iss_2014-10-10_720add61-d17a-40fa-ba0c-b48ea7ab135f.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Update on Offering in Gränges. Bookbuilding successfully completed. Shares priced at SEK 42.50 per share
Update on Offering in Gränges. Bookbuilding successfully completed. Shares priced at SEK 42.50 per share
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO
THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA
Orkla announces the successful completion of the bookbuilding period for the
initial public offering of the shares of Gränges AB (publ) ("Gränges" or the
"Company") and the listing on NASDAQ Stockholm (the "Offering"). The Offering
was over-subscribed and attracted strong interest, both from Swedish and
international institutional investors as well as from the general public in
Sweden and Norway.
The Offering in brief
1. The offering price has been set at SEK 42.50 per share, corresponding to a
market capitalization of Gränges of approximately SEK 3.2 billion.
2. In this Offering Orkla (through its wholly owned subsidiary Orkla
Industriinvesteringar AB) is selling 60 percent of its shareholding in Gränges,
corresponding to 44,783,600 shares.
3. The over-allotment option is up to 15 per cent of the Offering, corresponding
to 6,717,500 shares1.
4. The Offering comprises 51,501,100 shares corresponding to approximately 69
percent of the total number of shares in the Company, assuming the over-
allotment option is exercised in full.
5. Trading in Gränges' shares on NASDAQ Stockholm begins today, October
10, 2014, under the ticker "GRNG".
6. Orkla will receive gross proceeds from the Offering of approximately SEK 2.2
billion (assuming that the over-allotment is exercised in full), supplemented by
the SEK 1.65 billion Orkla received as dividends in September 2014.
7. Following the completion of the Offering, Orkla will own 40% of the shares of
Gränges if the over-allotment option is not exercised, or 31% if the over-
allotment option is exercised in its entirety.
Carnegie and SEB acted as Joint Global Coordinators and Joint Bookrunners in
connection with the Offering. Handelsbanken Capital Markets and Danske Bank
acted as Joint Bookrunners.
Reference is made to the appendix to this announcement for information on the
transaction in accordance with Section 3.4 of the Continuing Obligations for
Stock Exchange Listed Companies.
Orkla ASA,
Oslo, 10 October 2014
For further information, please contact:
Rune Helland, SVP Investor Relations
Tel: +47 97 71 32 50
1) The over-allotment option may be exercised by the Joint Global Coordinators
through November 10, 2014.
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO
THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA
DISCLAIMERS
This announcement is not an offer to buy any securities issued by Gränges AB
(publ) (the "Company") in any jurisdiction where such offer or sale would be
unlawful.
In any EEA Member State, other than Sweden and Norway, that has implemented
Directive 2003/71/EC as amended (together with any applicable implementing
measures in any member State, the "Prospectus Directive"), this communication is
only addressed to and is only directed at qualified investors in that Member
State within the meaning of the Prospectus Directive.
This document and the information contained herein are not for distribution in
or into the United States of America. This document does not constitute an offer
to sell, or a solicitation of an offer to purchase, any securities in the United
States. Any securities referred to herein have not been and will not be
registered under the U.S. Securities Act of 1933, as amended (the "Securities
Act"), and may not be offered or sold within the United States absent
registration or an applicable exemption from, or in a transaction not subject
to, the registration requirements of the Securities Act. There is no intention
to register any securities referred to herein in the United States or to make a
public offering of the securities in the United States.
In the United Kingdom, this document and any other materials in relation to the
securities described herein is only being distributed to, and is only directed
at, and any investment or investment activity to which this document relates is
available only to, and will be engaged in only with, "qualified investors" (as
defined in section 86(7) of the Financial Services and Markets Act 2000) and who
are (i) persons having professional experience in matters relating to
investments who fall within the definition of "investment professionals" in
Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 (the "Order"); or (ii) high net worth entities falling
within Article 49(2)(a) to (d) of the Order (all such persons together being
referred to as "relevant persons"). Persons who are not relevant persons should
not take any action on the basis of this document and should not act or rely on
it.
Any offering of securities will be made by means of a prospectus that may be
obtained from the issuer or selling security holder and that will contain
detailed information about the Company and management, as well as financial
statements. This document is an advertisement and not a prospectus for the
purposes of the Prospectus Directive. Investors should not subscribe for any
securities referred to in this document except on the basis of information
contained in the prospectus.
Matters discussed in this release may constitute forward-looking statements.
Forward-looking statements are statements that are not historical facts and may
be identified by words such as "believe," "expect," "anticipate," "intends,"
"estimate," "will," "may," "continue," "should" and similar expressions. The
forward-looking statements in this release are based upon various assumptions,
many of which are based, in turn, upon further assumptions. Although the
Company believes that these assumptions were reasonable when made, these
assumptions are inherently subject to significant known and unknown risks,
uncertainties, contingencies and other important factors which are difficult or
impossible to predict and are beyond its control. Such risks, uncertainties,
contingencies and other important factors could cause actual events to differ
materially from the expectations expressed or implied in this release by such
forward-looking statements.
The information, opinions and forward-looking statements contained in this
release speak only as at its date, and are subject to change without notice.
This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
[HUG#1862023]